Advertisement
AMRN vs CYPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Buy and CYPH is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMRN’s FA Score shows that 0 FA rating(s) are green whileCYPH’s FA Score has 1 green FA rating(s).
- AMRN’s FA Score: 0 green, 5 red.
- CYPH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMRN’s TA Score shows that 4 TA indicator(s) are bullish while CYPH’s TA Score has 7 bullish TA indicator(s).
- AMRN’s TA Score: 4 bullish, 6 bearish.
- CYPH’s TA Score: 7 bullish, 4 bearish.
Price Growth
AMRN (@Pharmaceuticals: Major) experienced а -9.10% price change this week, while CYPH (@Investment Managers) price change was +5.54% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.57%. For the same industry, the average monthly price growth was +11.20%, and the average quarterly price growth was +6.94%.
The average weekly price growth across all stocks in the @Investment Managers industry was -2.51%. For the same industry, the average monthly price growth was -2.32%, and the average quarterly price growth was -11.94%.
Industries' Descriptions
@Pharmaceuticals: Major (-1.57% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Investment Managers (-2.51% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
| AMRN | CYPH | AMRN / CYPH | |
| Capitalization | 307M | 74.4M | 413% |
| EBITDA | -24.36M | -56.75M | 43% |
| Gain YTD | 5.339 | -39.767 | -13% |
| P/E Ratio | N/A | 17.07 | - |
| Revenue | 217M | 0 | - |
| Total Cash | 308M | 6.69M | 4,605% |
| Total Debt | 5.59M | 38K | 14,697% |
AMRN | CYPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 95 | 99 | |
PRICE GROWTH RATING 1..100 | 58 | 55 | |
P/E GROWTH RATING 1..100 | 100 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMRN's Valuation (83) in the Pharmaceuticals Other industry is in the same range as CYPH (96) in the Biotechnology industry. This means that AMRN’s stock grew similarly to CYPH’s over the last 12 months.
AMRN's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CYPH (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to CYPH’s over the last 12 months.
AMRN's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as CYPH (99) in the Biotechnology industry. This means that AMRN’s stock grew similarly to CYPH’s over the last 12 months.
CYPH's Price Growth Rating (55) in the Biotechnology industry is in the same range as AMRN (58) in the Pharmaceuticals Other industry. This means that CYPH’s stock grew similarly to AMRN’s over the last 12 months.
CYPH's P/E Growth Rating (13) in the Biotechnology industry is significantly better than the same rating for AMRN (100) in the Pharmaceuticals Other industry. This means that CYPH’s stock grew significantly faster than AMRN’s over the last 12 months.
| AMRN | CYPH | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 86% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 85% |
| Momentum ODDS (%) | 4 days ago 87% | 4 days ago 90% |
| MACD ODDS (%) | 4 days ago 87% | 4 days ago 84% |
| TrendWeek ODDS (%) | 4 days ago 86% | 4 days ago 87% |
| TrendMonth ODDS (%) | 4 days ago 75% | 4 days ago 90% |
| Advances ODDS (%) | 20 days ago 74% | 4 days ago 89% |
| Declines ODDS (%) | 4 days ago 86% | 19 days ago 90% |
| BollingerBands ODDS (%) | 4 days ago 79% | 5 days ago 89% |
| Aroon ODDS (%) | 4 days ago 90% | 6 days ago 88% |
Advertisement
AMRN and
Correlation & Price change
A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with CNTB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then CNTB could also see price increases.
| Ticker / NAME | Correlation To AMRN | 1D Price Change % | ||
|---|---|---|---|---|
| AMRN | 100% | -1.21% | ||
| CNTB - AMRN | 55% Loosely correlated | -9.96% | ||
| HRTX - AMRN | 44% Loosely correlated | +0.60% | ||
| MGNX - AMRN | 44% Loosely correlated | +3.93% | ||
| ALXO - AMRN | 43% Loosely correlated | -7.29% | ||
| ARWR - AMRN | 40% Loosely correlated | -3.00% | ||
More | ||||
CYPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.
| Ticker / NAME | Correlation To CYPH | 1D Price Change % | ||
|---|---|---|---|---|
| CYPH | 100% | -0.60% | ||
| INKT - CYPH | 42% Loosely correlated | +0.90% | ||
| AXON - CYPH | 40% Loosely correlated | -3.32% | ||
| SABS - CYPH | 36% Loosely correlated | -2.36% | ||
| AMRN - CYPH | 35% Loosely correlated | -1.21% | ||
| ALLR - CYPH | 30% Poorly correlated | -3.00% | ||
More | ||||